The Effect of Mild Weight Loss on Circulating Metabolite Profiles
Study Details
Study Description
Brief Summary
To determine whether low calorie diet (LCD)-induced weight reduction caused changes in plasma metabolites and metabolic traits from baseline.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Over a 12-week clinical intervention period, a randomized, controlled study was carried out; overweight subjects consumed a LCD (approximately 300kcal/d deficit, n=47) or a weight-maintenance diet (control, n=50) were included for analyzing plasma samples and metabolites using an ultra-performance liquid chromatography and mass spectrometry (UPLC-LTQ/Orbitrap MS).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Control group Usual dietary intake group |
Behavioral: Control group
Recommend to consume usual diet during 12-week study period
|
Experimental: LCD group Low calorie diet (LCD) group (300kcal/day intake reduction) |
Behavioral: LCD group
Recommended to reduce calorie intake (a 300 kcal/day); educated to take out 1/3 of a bowl of rice from per meal a day for an easier application of 100kcal deficits, thereby reducing a 300kcal/3 meal/day
|
Outcome Measures
Primary Outcome Measures
- Visceral fat area at L4 (CT) [At baseline]
- Visceral fat area at L4 (CT) [At 12-week follow-up]
- Change in visceral fat area at L4 from baseline [At baseline and 12-week follow-up]
- Putatively identified plasma metabolites (Normalized peak intensities) [At baseline]
- Putatively identified plasma metabolites (Normalized peak intensities) [At 12-week follow-up]
- Changes in putatively identified plasma metabolites (Normalized peak intensities) from baseline [At baseline and 12-week follow-up]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Able to give informed consent
-
20-65 years old
-
Males and females
-
Overweight (25.0 kg/m²≤ Body mass index <30 kg/m²)
-
Nondiabetic (Fasting glucose <126 mg/dL)
Exclusion Criteria:
-
Unstable body weight (body weight change >1 kg within 3 months before screening)
-
Consumption of medication that affects body weight or energy expenditure
-
Pregnancy or breast-feeding
-
Hypertension, type 2 diabetes, cardiovascular disease, cerebrovascular disease, or thyroid disease
-
Liver disease, kidney disease, or gastrointestinal disease
-
Acute or chronic infections
-
Any acute or chronic disease requiring treatment
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Yonsei University | Seoul | Korea, Republic of | 03722 |
Sponsors and Collaborators
- Yonsei University
Investigators
- Principal Investigator: Jong Ho Lee, PhD, Yonsei University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Wt loss_metabolites